Stay updated on Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.

Latest updates to the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe page history shows Revision: v3.4.2 added and Revision: v3.4.1 removed, indicating a minor update to the history entries rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision: v3.4.1 has been added to the history, and the notices about funding lapse and Revision: v3.4.0 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check22 days agoChange DetectedA site-wide notice about a lapse in government funding was added, informing users that information may not be up to date and directing them to cc.nih.gov and opm.gov; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check29 days agoChange Detected- Show glossary option and color-coded change indicators (green for additions, red for deletions) on the Record History page. A new revision label (Revision: v3.4.0) is displayed to reflect the update.SummaryDifference0.6%

- Check36 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3 on the page, indicating a minor update to the site’s version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedA new history entry on 2025-12-26 adds a Study Status update (version 48). A prior entry from 2025-12-02 was removed.SummaryDifference0.2%

Stay in the know with updates to Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.